Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer

Clinical trial NCT01752517 · UNKNOWN

Trial details

NCT number: NCT01752517
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Small Cell Lung Cancer

Start date: 2012-12-01
Primary completion: 2014-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.